Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ALGS Aligos Therapeutics Inc

40,3388

1,99 (5,19%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Aligos Therapeutics Charts.

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Aligos Therapeutics Charts.

News Aligos Therapeutics Inc

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 13 Dezember 2024 (1 Woche vor) • GlobeNewswire Inc.

Aligos Therapeutics to Present at Investor Conferences in December
Dienstag 26 November 2024 (4 Wochen vor) • GlobeNewswire Inc.

Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
Dienstag 19 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 6 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 6 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
Mittwoch 6 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 6 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024
Mittwoch 30 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
Dienstag 22 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024
Dienstag 15 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 11 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Aligos Therapeutics Inc News-Artikel

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen